HIFU‐Driven Targeted Pyroptosis Therapy in Basal‐Like Breast Cancer
This study presents a HIFU‐driven pyroptosis strategy for BLBC treatment. Combining HIFU with platelet‐membrane hybridized liposomes encapsulating mitoxantrone enhances tumor targeting and efficacy. The synergistic treatment modulates key epigenetic regulators and activates the pyroptotic pathway through ROS generation and inflammasome signaling ...
Xiaomin Su +13 more
wiley +1 more source
Exploratory study on autoantibodies to arginine-rich human peptides mimicking Epstein-Barr virus in women with post-COVID and myalgic encephalomyelitis/chronic fatigue syndrome. [PDF]
Hoheisel F +14 more
europepmc +1 more source
In hepatocellular carcinoma (HCC), the m6A‐modified circRAPGEF1 destabilizes ASS1 mRNA via competitive binding to IGF2BP3, driving aspartate metabolic reprogramming in liver cancer stem cells (LCSCs). This cascade enhances stemness properties and reduces sorafenib sensitivity in LCSCs, thereby identifying circRAPGEF1 as a promising therapeutic target ...
Juanyi Shi +13 more
wiley +1 more source
Genome-wide identification of <i>MYBL2</i> in Brassicaceae, with a focus on the expression pattern of regulating anthocyanin synthesis in <i>Brassica</i> crops. [PDF]
Wang C +7 more
europepmc +1 more source
A Modular and Customizable CRISPR/Cas Toolkit for Epigenome Editing of Cis‐regulatory Modules
Epigenome editing surpasses genome editing in gene regulation. Modular epigenome editing frameworks are developed to interrogate cis‐regulome, enabling tunable reprogramming of cis‐elements, uncovering their epigenetic responsiveness and cross‐species portability.
Lingrui Zhang +6 more
wiley +1 more source
Prognostic impact of gene alterations via homologous recombination DNA repair gene alteration status in pancreatic ductal adenocarcinoma. [PDF]
Kawanaka Y +9 more
europepmc +1 more source
III. On a new series of bodies homologous to hydrocyanic acid.—III [PDF]
A. W. Hofmann
openalex +1 more source
A vitiligo‐derived gene signature predicts response to immune checkpoint blockade across multiple cancer cohorts, providing a framework for patient stratification. Building on this, Fulvestrant—a clinically approved estrogen receptor degrader—further enhances antitumor immunity by reprogramming tumor‐associated macrophages and promoting CD8⁺ T cell ...
Jie Zhu +8 more
wiley +1 more source
Homologous recombination deficiency and survival in ovarian high-grade serous carcinoma by self-reported race. [PDF]
Lawson-Michod KA +13 more
europepmc +1 more source
Random Assortment in Inheritance of Distinguishable Homologous Chromosomes
Max Coulter
openalex +2 more sources

